Whether the underlying risk of high bleeding risk (HBR) influences the relationship of high\nthrombotic risk (HTR) features with adverse events after drug-eluting stent implantation remains unclear. The\npurpose of this study was to evaluate (1) the prognostic effect of ESC guideline-endorsed HTR features on longterm\nclinical outcomes and (2) whether the outcomes of HTR versus non-HTR features vary by HBR status.\nMethods: Ten thousand one hundred sixty-seven consecutive patients who underwent percutaneous coronary\nintervention between January 2013 and December 2013 were prospectively enrolled in Fuwai PCI Registry. Patients\nwho are at HTR were defined as: diffuse multivessel disease in diabetic patients, chronic kidney disease, at least\nthree stents implanted, at least three stents lesions treated, bifurcation with two stents implanted, total stent............
Loading....